Agfa completes Sterling purchaseAgfa's acquisition of Sterling Diagnostic Imaging is now complete. The Ridgefield Park, NJ-based film and PACS vendor has acquired all the capital stock of Sterling's parent company, SDI Holding Corp. A management
Agfa's acquisition of Sterling Diagnostic Imaging is now complete. The Ridgefield Park, NJ-based film and PACS vendor has acquired all the capital stock of Sterling's parent company, SDI Holding Corp. A management team for the combined companies has also been named. John Glass, managing director for Agfa-Gevaert's medical imaging business group, will head the combined businesses worldwide. Sterling executive vice president and COO Ernest Waaser will assume responsibilities previously held by Glass at Agfa, while Sterling chairman and CEO Rodney Wolford will stay on for a limited time to assist Glass and Waaser during the transition.
In other Agfa news, the firm's MIL-PACS organization will install PACS technology at a U.S. Naval Branch Medical Clinic in Key West, FL. The system will allow technicians in Key West to transmit digitized x-ray images to radiologists at the U.S. Naval Hospital in Jacksonville, FL. System delivery is slated for early August, with installation targeted for completion by late September.
The company has also received a $25 million contract from Queensland Health of Australia, which will use the firm's Impax offering to link the imaging units at five tertiary teaching hospitals. Agfa will serve as a systems integrator, linking Impax with four other major digital technology suppliers. Queensland Health hopes to convert to a totally filmless environment within two to three years, according to Agfa.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.